Segundo o Sistema de Classificação Biofarmacêutica (SCB), a dissolução e a . Eles objetivaram verificar a dissolução in vitro da formulação em uma fase. MODELOS FARMACOCINÉTICOSFASE PK FASE BIOFARMACEUTICA FASE PD Dr. Pedro Alva Plasencia MODELOS FARMACOCINÉTICOS. Fase Biofarmaceutica Pertenece al campo de la Química Farmacéutica. Tiene como propósito colocar en forma adecuada el principio activo a disposición del.

Author: Mira Kazrarg
Country: Panama
Language: English (Spanish)
Genre: Music
Published (Last): 26 April 2006
Pages: 344
PDF File Size: 2.61 Mb
ePub File Size: 11.2 Mb
ISBN: 316-3-55191-299-8
Downloads: 74832
Price: Free* [*Free Regsitration Required]
Uploader: Kazilrajas

Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Os autores observaram que os resultados foram semelhantes utilizando a pele humana e a pele de orelha de porco.

The Caco-2 cell, a human colon adenocarcinoma, undergoes spontaneous enterocytic differentiation in culture.

Bioavailability and bioequivalence of pharmaceutical formulations. O experimento foi executado em triplicata. Criterios y requisitos generales de Intercambiabilidad biodisponibilidad o bioequivalencia. In-vitro dissolution profile comparison: These include diffusion studies with intestinal segments biofaramceutica various species or with cultured cell monolayer.

Response to Kikwood, TBL.: Validation of liquid chromatographic and gas chromatographic methods.


Sistema de Clasificación Biofarmaceútica

According to Biopharmaceutical Biofarmxceutica System Classification BSCthe dissolution and the intestinal permeation of a drug can limit the absorption and, consequently, the therapeutic action of that drug. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. Intestinal permeability of chlropyrifos using the single-pass intestinal perfusion method in the rat.

Intestinal cell culture models. United States Pharmacopeia30 th ed. Estas podem mimetizar a permeabilidade do intestino delgado humano para transporte passivo transcelular e paracelular. The relationship between in vitro drug dissolution and in vivo absorption.

Sus requisitos deben especificarse para un cierto periodo o desde un cierto momento de la partida. Prediction of pharmacokinetics properties using experimental approaches during early drug discovery.

Drug absorption sites in the gastrintestinal tract and dosage forms for site-specific delivery. Intestinal absorption of drug mediated by drug transporters: Valores similares de LogP ow, em torno a 0,7, foram encontrados na literatura para os diferentes meios aquosos.


Journal of Pharmaceutical and Biomedical Analysis, ; Dissolution testing as a prognostic tool for oral drug absorption: Interactions with peptide transporters. Acesso em 10 jun An exact, confidence interval from untransformed data for the ratio of two formulation means.


La cual debe ser realizada por el fabricante del M. Criterios y requisitos para realizar pruebas de intercambiabilidad biodisponibilidad o bioequivalencia en humanos.

Treatment of bioequivalence data: Caco-2 cells have been the most extensively characterized and useful cell models.

All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.

Thermal, diffractometric, morphological and reological drug profiles were obtained. A century of dissolution research: Correlation of “in vitro” release and “in vivo” absorption characteristics of rifampicin from ethylcellulose coated nonpareil beads. Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat.